UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~Section 13 0ROR 15 (Dd) OFof ~~THE~~the Securities Exchange Act of 1934

~~SECURITIES~~Date ~~EXCHANGE~~of ~~ACT~~Report OF(Date ~~1934~~of earliest event reported): March 30, 2020

~~Date~~Commission ofFile ~~Report (Date of earliest event reported)~~Number: ~~October 31, 2019~~000-1449574

Bravatek Solutions, Inc. (Exact name of ~~registrant~~Registrant as specified in its charter)

Colorado

Colorado		32-0201472
(State of incorporation)		(IRS Employer ID Number)

~~(State~~2028 orE ~~Other~~Ben ~~Jurisdiction~~White ofBlvd, ~~Incorporation)~~Suite 240-2835

000-1449574		32-0201472
(Commission File Number)		(IRS Employer Identification No.)
2028 E Ben White Blvd, Suite 240-2835, Austin, Texas		78741
(Address of Principal Executive Offices)		(Zip Code)

Austin, TX 78741

(Address of principal executive offices)

(866) 204-6703

(Registrant’s telephone number, including area code)

~~______________________________________________~~Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

~~Securities~~Indicate ~~registered~~by ~~pursuant~~check tomark ~~Section~~whether 12the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (b§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act: of 1934 (§240.12b-2 of this chapter).

~~Title~~Emerging ofgrowth ~~each~~company ~~class~~☐ ~~Trading Symbols(s) Name of each exchange on which registered N/A N/A N/A~~

~~Indicate~~If an emerging growth company, indicate by check mark ~~whether~~if the registrant ishas anelected ~~emerging~~not ~~growth~~to ~~company~~use asthe ~~deﬁned~~extended intransition ~~Rule~~period ~~405~~for ofcomplying ~~the~~with ~~Securities~~any ~~Act~~new ofor ~~1933~~revised ~~(§230.405~~financial ofaccounting ~~this~~standards ~~chapter)~~provided orpursuant ~~Rule~~to ~~12b-2~~Section 13(a) of the ~~Securities~~ Exchange Act ~~of 1934 (§240~~.~~12b-2~~ ~~of this chapter).~~☐

~~Emerging~~Item ~~growth~~8.01 ~~company~~OTHER ¨EVENTS

IfBravatek anSolutions, ~~emerging~~Inc. ~~growth~~(the ~~company,~~"Company") ~~indicate~~will bybe ~~check~~relying ~~mark~~on ifthe Securities and Exchange Commission's Order under Section 36 of the ~~registrant~~Securities ~~has~~Exchange ~~elected~~Act ~~not~~of 1934 Granting Exemptions From Specified Provisions of the Exchange Act and Certain Rules Thereunder dated March 4, 2020 (Release No. 34-88318) (the "Order") to ~~use~~delay the ~~extended~~filing ~~transition~~of ~~period~~its Annual Report on Form 10-K for ~~complying~~the year ended December 31, 2019 (the "Report") due to the circumstances related to COVID-19. In particular, COVID-19 has caused severe disruptions in transportation and limited access to the Company's facilities due, among other things, to our immediate response to assist government officials in dealing effectively with ~~any~~COVID-19, ~~new~~resulting orin ~~revised~~limited ~~ﬁnancial~~support ~~accounting~~from ~~standards~~its ~~provided~~staff ~~pursuant~~and professional advisors. This has, in turn, delayed the Company's ability to ~~Section~~complete 13its audit and prepare the Report. Notwithstanding the foregoing, the Company expects to file the Report no later than May 14, 2020 (awhich is 45 days from the Report's original filing deadline of March 30, 2020). In light of the ~~Exchange~~current ~~Act.~~COVID-19 ¨pandemic, the Company will be including the following Risk Factor in its Report:

~~Item~~An ~~8.01~~occurrence ~~Other~~of ~~Events~~an uncontrollable event such as the COVID-19 pandemic may negatively affect our operations.

OnThe ~~October~~occurrence ~~31,~~of ~~2019,~~an ~~Bravatek~~uncontrollable ~~Solutions,~~event ~~Inc.~~such (as the ~~“Company”)~~COVID-19 ~~entered~~pandemic ~~into~~may anegatively ~~binding~~affect ~~letter~~our ~~of intent with RMA Armament, Inc~~operations., anA ~~Iowa~~pandemic ~~company~~typically ~~engaged~~results in ~~the~~social ~~development~~distancing, ~~and~~travel ~~manufacture~~bans ofand ~~body armor (“RMA”)~~quarantine, ~~pursuant~~and tothis ~~which~~may ~~the~~limit ~~parties~~access ~~would~~to ~~use~~our ~~their~~facilities, ~~best~~customers, ~~efforts~~management, tosupport ~~negotiate~~staff and ~~execute~~professional aadvisors. ~~definitive~~These ~~stock~~factors, ~~purchase~~in ~~agreement~~turn, ~~whereby~~may ~~the~~not ~~Company~~only ~~would~~impact ~~issue~~our ~~RMA shares of non-convertible preferred stock entitling RMA to $1~~operations,~~900,000~~ infinancial ~~cash~~condition ~~payments~~and ~~from~~demand ~~the~~for ~~Company~~our ~~(the~~goods ~~“Bravatek~~and ~~Payment~~services ~~Amount”),~~but inour ~~consideration~~overall ofability ~~RMA agreeing~~ to ~~make~~react ~~quarterly~~timely ~~payments~~ to ~~BVTK~~mitigate ~~consisting~~the ofimpact ~~49%~~ of ~~the~~this ~~operating~~event. ~~profits of RMA~~Also, ~~with~~it ~~39%~~may ofhamper ~~the~~our ~~49%~~efforts ~~retained~~to bycomply ~~RMA~~with ~~and~~our ~~credited~~filing ~~against~~obligations ~~the~~with ~~Bravatek Payment Amount until~~ the ~~Bravatek~~Securities ~~Payment Amount has been deemed paid in full,~~ and ~~10%~~Exchange ~~of the 49% paid to Bravatek by RMA quarterly~~Commission.

~~The~~Item ~~foregoing description of the letter of intent and its terms is qualified in its entirety by the full text of the agreement, which is filed as Exhibit 99~~9.101 ~~to,~~FINANCIAL ~~and~~STATEMENTS ~~incorporated~~AND ~~by reference in, this report.~~ EXHIBITS

~~Item 9.01 Financial Statements and~~ Exhibits.

~~The exhibit listed in the following Exhibit Index is filed as part of this report:~~None

~~99.1 Letter of Intent with RMA dated October 29, 2019.~~2

2SIGNATURES

~~SIGNATURES~~Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Bravatek Solutions, Inc.

Date: March 30, 2020	By:	/s/ Thomas A. Cellucci
		Thomas A. Cellucci
		Chief Executive Officer

	BRAVATEK SOLUTIONS, INC.
Date: November 5, 2019	By:	/s/ Thomas A. Cellucci
		Thomas A. Cellucci
		Chief Executive Officer

Filing Compare · Bravatek Solutions, Inc.